| Target | Drug (INN) | PubChem CID |
|---|---|---|
| ABL1 | zanamivir | 60855 |
| ABL1 | dasatinib | 3062316 |
| ABL1 | ponatinib | 24826799 |
| ABL1 | bosutinib | 5328940 |
| ABL1 | nilotinib | 644241 |
| ABL1 | brigatinib | 68165256 |
| ABL1 | imatinib | 5291 |
| ABL1 | regorafenib | 11167602 |
| ABL1 | fostamatinib | 11671467 |
| ABL1 | busulfan | 2478 |
| ABL1 | vandetanib | 3081361 |
| ABL1 | axitinib | 6450551 |
| ABL1 | pilocarpine | 5910 |
| Target (Uniprot AC) |
Predicted Drug (INN) |
PubChem CID | Target Prediction Score (Range: 0~1) |
Target Binding Prediction (Positive binding: 1) |
Novel Prediction (Novel positive: 1) |
|---|---|---|---|---|---|
| ABL1 (P00519) | famotidine | 5702160 | 0.1527 | 0 | - |
| ABL1 (P00519) | afatinib | 10184653 | 0.1503 | 0 | - |
| ABL1 (P00519) | neratinib | 9915743 | 0.1485 | 0 | - |
| ABL1 (P00519) | naldemedine | 54732242 | 0.1473 | 0 | - |
| ABL1 (P00519) | tranylcypromine | 441233 | 0.1244 | 0 | - |
| ABL1 (P00519) | 1-menthyl salicylate | 20055232 | 0.1161 | 0 | - |
| ABL1 (P00519) | cangrelor tetrasodium | 10260031 | 0.1136 | 0 | - |
| ABL1 (P00519) | metocurine iodide | 24244 | 0.1084 | 0 | - |
| ABL1 (P00519) | akos015918055 | 46864002 | 0.0916 | 0 | - |
| ABL1 (P00519) | iopromide | 3736 | 0.0837 | 0 | - |
| ABL1 (P00519) | hexamidine | 65130 | 0.0831 | 0 | - |
| ABL1 (P00519) | streptozocin | 2733335 | 0.0805 | 0 | - |
| ABL1 (P00519) | famotidine | 5353622 | 0.0797 | 0 | - |
| ABL1 (P00519) | metrizamide | 443944 | 0.0789 | 0 | - |
| ABL1 (P00519) | cobimetinib fumarate | 71491931 | 0.0785 | 0 | - |
| ABL1 (P00519) | midostaurin | 9829523 | 0.0772 | 0 | - |
| ABL1 (P00519) | pazopanib hydrochloride | 11525740 | 0.0655 | 0 | - |
| ABL1 (P00519) | mercury diiodide | 24485 | 0.0655 | 0 | - |
| ABL1 (P00519) | tetrahydrobiopterin | 135402045 | 0.0647 | 0 | - |
| ABL1 (P00519) | brodimoprim | 68760 | 0.0565 | 0 | - |
| ABL1 (P00519) | 7553-56-2 | 807 | 0.0515 | 0 | - |
| ABL1 (P00519) | lapatinib | 208908 | 0.0345 | 0 | - |
| ABL1 (P00519) | 25416-65-3 | 131664344 | 0.032 | 0 | - |
| ABL1 (P00519) | (2s)-2-ammonio-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoate | 25201348 | 0.0248 | 0 | - |
| ABL1 (P00519) | 24812736 | 0.0104 | 0 | - | |
| ABL1 (P00519) | rose bengal (photoactivated) | 25474 | 0.0053 | 0 | - |
| ABL1 (P00519) | liothyronine sodium | 23666110 | 0.0042 | 0 | - |
| ABL1 (P00519) | ruxolitinib phosphate | 25127112 | 0.003 | 0 | - |
| ABL1 (P00519) | ruxolitinib | 25126798 | 0.0027 | 0 | - |
| ABL1 (P00519) | 25416-65-3 | 23667619 | 0.0027 | 0 | - |
| ABL1 (P00519) | liotrix | 71371 | 0.0025 | 0 | - |
| ABL1 (P00519) | thyroxine zwitterion | 25201456 | 0.0025 | 0 | - |
| ABL1 (P00519) | tofacitinib | 9926791 | 0.0019 | 0 | - |
| ABL1 (P00519) | monosodium d-thyroxine hydrate | 23677961 | 0.0017 | 0 | - |
| ABL1 (P00519) | d-thyroxine | 8730 | 0.0013 | 0 | - |
| ABL1 (P00519) | dl-thyroxine | 853 | 0.001 | 0 | - |